Three elements make today easier treatment of haemophilia: new drugs, pharmacokinetics and physical activity“. So Giuseppe Malcangi, Uosd Hemophilia and Thrombosis Center of the Policlinico di Bari he discussed the new perspectives of haemophilia treatment during the seventh stage of ‘Articoliamo’, a campaign supported by Sobi with the patronage of FedEmo and dedicated to promoting joint care and well-being in people with haemophilia.
“New drugs with a prolonged half-life make it possible to increase the interval between drug administrations and thus have a greater amount of factor VIII in the blood and therefore more protection – assures the haematologist – then there is pharmacokinetics, which allows us to quantify the duration of the drug in the body and finally physical activity: patients who practice it ensure greater protection “. A research commissioned by Sobi has revealed how the physical activity of patients has changed in the Covid era: 34% have stopped doing it, since it rises to 50% in patients with serious diseases.
“The approach to the haemophilia patient today is increasingly multidisciplinary – Malcangi concludes – the hematologist remains the director but the involvement of a physiatrist and physiotherapist and their rehabilitation plans is important to avoid joint problems “.